Jane Street’s ETF Series Solutions Trust Range Cancer Therapeutics ETF CNCR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-36,741
| Closed | -$346K | – | 5568 |
|
|
2025
Q1 | $346K | Buy |
36,741
+20,127
| +121% | +$190K | ﹤0.01% | 4410 |
|
|
2024
Q4 | $205K | Buy |
+16,614
| New | +$205K | ﹤0.01% | 5069 |
|
|
2024
Q2 | – | Sell |
-11,512
| Closed | -$191K | – | 6135 |
|
|
2024
Q1 | $191K | Buy |
+11,512
| New | +$191K | ﹤0.01% | 5052 |
|
|
2023
Q4 | – | Sell |
-13,798
| Closed | -$151K | – | 5754 |
|
|
2023
Q3 | $151K | Buy |
+13,798
| New | +$151K | ﹤0.01% | 4511 |
|
|
2022
Q4 | – | Sell |
-51,317
| Closed | -$752K | – | 5587 |
|
|
2022
Q3 | $752K | Buy |
+51,317
| New | +$752K | ﹤0.01% | 3122 |
|
|
2021
Q4 | – | Sell |
-24,656
| Closed | -$748K | – | 5378 |
|
|
2021
Q3 | $748K | Buy |
24,656
+6,255
| +34% | +$190K | ﹤0.01% | 2982 |
|
|
2021
Q2 | $587K | Sell |
18,401
-11,491
| -38% | -$367K | ﹤0.01% | 3245 |
|
|
2021
Q1 | $895K | Buy |
29,892
+7,060
| +31% | +$211K | ﹤0.01% | 2627 |
|
|
2020
Q4 | $724K | Sell |
22,832
-11,573
| -34% | -$367K | ﹤0.01% | 2407 |
|
|
2020
Q3 | $945K | Sell |
34,405
-11,754
| -25% | -$323K | ﹤0.01% | 1844 |
|
|
2020
Q2 | $1.25M | Buy |
+46,159
| New | +$1.25M | ﹤0.01% | 1751 |
|
|
2019
Q3 | – | Sell |
-16,474
| Closed | -$348K | – | 3478 |
|
|
2019
Q2 | $348K | Buy |
+16,474
| New | +$348K | ﹤0.01% | 2605 |
|
|
2019
Q1 | – | Sell |
-30,018
| Closed | -$567K | – | 3323 |
|
|
2018
Q4 | $567K | Buy |
30,018
+21,857
| +268% | +$413K | ﹤0.01% | 2010 |
|
|
2018
Q3 | $203K | Sell |
8,161
-13,743
| -63% | -$342K | ﹤0.01% | 3131 |
|
|
2018
Q2 | $529K | Sell |
21,904
-28,234
| -56% | -$682K | ﹤0.01% | 2211 |
|
|
2018
Q1 | $1.46M | Buy |
+50,138
| New | +$1.46M | ﹤0.01% | 1271 |
|
|
2017
Q4 | – | Sell |
-43,507
| Closed | -$1.18M | – | 3086 |
|
|
2017
Q3 | $1.18M | Buy |
43,507
+17,661
| +68% | +$478K | ﹤0.01% | 1241 |
|
|
2017
Q2 | $595K | Buy |
+25,846
| New | +$595K | ﹤0.01% | 1748 |
|
|
2017
Q1 | – | Sell |
-41,822
| Closed | -$888K | – | 2767 |
|
|
2016
Q4 | $888K | Buy |
41,822
+31,150
| +292% | +$661K | ﹤0.01% | 1330 |
|
|
2016
Q3 | $275K | Sell |
10,672
-15,406
| -59% | -$397K | ﹤0.01% | 2287 |
|
|
2016
Q2 | $593K | Buy |
26,078
+15,341
| +143% | +$349K | ﹤0.01% | 1615 |
|
|
2016
Q1 | $233K | Buy |
+10,737
| New | +$233K | ﹤0.01% | 2155 |
|